- Home
- NGNE vs FBIOP Comparison
NGNE vs FBIOP Comparison
Compare NGNE & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGNE
- FBIOP
- Stock Information
- Founded
- NGNE 2003
- FBIOP N/A
- Country
- NGNE United States
- FBIOP United States
- Employees
- NGNE N/A
- FBIOP 186
- Industry
- NGNE Biotechnology: Pharmaceutical Preparations
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- NGNE Health Care
- FBIOP Health Care
- Exchange
- NGNE Nasdaq
- FBIOP Nasdaq
- Market Cap
- NGNE N/A
- FBIOP N/A
- IPO Year
- NGNE N/A
- FBIOP N/A
- Fundamental
- Price
- NGNE $9.85
- FBIOP $5.79
- Analyst Decision
- NGNE Strong Buy
- FBIOP
- Analyst Count
- NGNE 5
- FBIOP 0
- Target Price
- NGNE $59.80
- FBIOP N/A
- AVG Volume (30 Days)
- NGNE 264.9K
- FBIOP N/A
- Earning Date
- NGNE 05-09-2025
- FBIOP N/A
- Dividend Yield
- NGNE N/A
- FBIOP N/A
- EPS Growth
- NGNE N/A
- FBIOP N/A
- EPS
- NGNE N/A
- FBIOP N/A
- Revenue
- NGNE $925,000.00
- FBIOP N/A
- Revenue This Year
- NGNE N/A
- FBIOP N/A
- Revenue Next Year
- NGNE N/A
- FBIOP N/A
- P/E Ratio
- NGNE N/A
- FBIOP N/A
- Revenue Growth
- NGNE N/A
- FBIOP N/A
- 52 Week Low
- NGNE $9.59
- FBIOP N/A
- 52 Week High
- NGNE $74.49
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- NGNE 27.54
- FBIOP 36.23
- Support Level
- NGNE $13.60
- FBIOP $6.26
- Resistance Level
- NGNE $16.64
- FBIOP $6.74
- Average True Range (ATR)
- NGNE 1.46
- FBIOP 0.29
- MACD
- NGNE -0.39
- FBIOP -0.06
- Stochastic Oscillator
- NGNE 6.55
- FBIOP 23.20
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.